Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06537232 · ClinicalTrials.gov registry record · NA

Greens-Based Crossover Trial to Improve Epigenetic Aging in Adults

A NA study of Aging, sponsored by Auburn University.

Active
Registry status
NA
Development phase
20
Enrollment target
1
Study location

NCT06537232 is a NA study of Aging that is active but no longer recruiting, run by Auburn University. The registered enrollment target is 20 participants, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06537232, a NA study of Aging, is active but no longer recruiting, sponsored by Auburn University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
20 participants
Enrollment target
1
Study location

Study Summary

The primary purpose of this study is to assess changes in epigenetic markers of aging and physiological parameters in overweight older adults consuming a mixed greens-based supplement over a 30-day period in a randomized crossover design.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Greens-based Supplement

Study Locations (1)

Alabama

  • Auburn University - Auburn

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2024-09-04
Est. Completion 2025-03
Phase NA

Sponsor

Auburn University

54 total trials

What the Registry Record Tells You About NCT06537232

The ClinicalTrials.gov registry entry for NCT06537232 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,195-participant average among 262 other Aging trials with a reported enrollment target (99% lower). The listed sponsor is Auburn University, which has 54 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Aging appearing as the primary indexed condition, and to 1 intervention - of which Greens-based Supplement is the first listed.

NCT06537232 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06537232 about?

NCT06537232 is a clinical study titled "Greens-Based Crossover Trial to Improve Epigenetic Aging in Adults". The primary purpose of this study is to assess changes in epigenetic markers of aging and physiological parameters in overweight older adults consuming a mixed greens-based supplement over a 30-day period in a randomized crossover design.

What is the current status of trial NCT06537232?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2024-09-04. Estimated completion is 2025-03.

What conditions does trial NCT06537232 study?

This clinical trial studies the following conditions: Aging.

What interventions are being tested in trial NCT06537232?

The interventions under investigation include: Greens-based Supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06537232?

This trial is sponsored by Auburn University, which has 54 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06537232 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Aging

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.